Excited to be included in Omdena #AI's "46 Groundbreaking AI-Enabled Biotech Companies of 2023" ➡️➡️

Thrilled to share that our study, Elemental Dynamics in Hair Accurately Predict Future Autism Spectrum Disorder Diagnosis, has been selected for Niel 'papers of the month'! Congrats to our amazing team and collaborators for this achievement! #autism factor.niehs.nih.gov/2023/3/papers/…

LinusBio is excited to present our innovation at #BioNJ’s BioPartnering Conference, April 18 at The Palace, Somerset Park, NJ. Come meet with us! #BioP2023 #PartneringForPossibility tinyurl.com/2p99hupn

LinusBio is taking the presentation stage at the 2023 BIO International Convention in Boston, June 5-8. We are thrilled to showcase our company's innovation in the field of precision exposome medicine. Click to send us a meeting request #BIO2023 login.partnering.bio.org/inova-business…

Exciting news! We are thrilled to announce we've successfully secured our A2 funding series, fueling international partnerships and production scale. #milestone #fundinground Read full details here ➡️ linusbio.com/a2-funding-ann…

Manish Arora LinusBio discusses the exposome, how the company’s test for autism works, and how this opens the potential for early intervention. Global Genes #RARECast globalgenes.org/raredaily/diag…

From baby teeth to a strand of hair: learn about our autism biomarker journey. Explore our peer-reviewed publications>> linusbio.com/publications/ #autism #research #exposomesequencing #diagnostictests #treatments

"Early Answers for Autism Are on the Way!" 🧩 Join us at the #SDBP2023 Annual Meeting, hosted by Society for Developmental & Behavioral Pediatrics . 📅 September 7-11, Minneapolis, MN. If you're attending, be sure to drop by and meet our team. Let's drive #AutismInnovation together!

📸 Captured a moment of #AutismInnovation at the #SDBP2023 Annual Meeting in Minneapolis, MN, which concluded today. 🧩 Our team was thrilled to be part of this journey towards Early Answers for Autism. A big thank you to all the attendees who stopped by and to Society for Developmental & Behavioral Pediatrics.

Thrilled to be part of BioSpace's prestigious NextGen Bio Class of 2024! Recognized among the top life sciences startups to watch, we're excited to contribute to innovation and make an impact in the industry. #NextGen2024

We are proud to be featured on FiercePharma 2023 #Fierce15 list of medical technology companies. Read the full article here ➡️ fiercebiotech.com/special-report… #Medtech #PrecisionMedicine

Another Phase III Trial Failure in Neuroscience: What Are We Doing Wrong? The time dimension is where the secrets of the CNS are hidden, says LinusBio CEO Dr. Manish Arora. Read more: ow.ly/TqMG50RtwSs

Innovative. Transformative. Pioneering. Big news is on the horizon; stay tuned! #ASD #Biomarker

"Our genes are static, whereas our exposome changes all the time. So how do we map something that is constantly dynamic?" LinusBio's CEO, Dr. Manish Arora, talks with Karen Jagoda about harnessing the exposome to generate novel biomarkers. empoweredpatientradio.com/exposome-platf…

We’re extremely proud to announce the launch of ClearStrand-ASD –a ground-breaking, first-of-its kind biomarker test that provides biochemical insights about autism as early as one month of age—using just a single strand of hair! clearstrandasd.com

Today, on World Autism Awareness Day, LinusBio is proud to announce our partnership with The BRAIN Foundation to advance biomarker-supported autism diagnosis and early intervention. Learn more➡️ lnkd.in/ewNVRU2x

The Washington Post recently covered the national conversation around large-scale autism research initiatives. LinusBio's CEO, Dr. Manish Arora, was invited to contribute his perspective. Read the full story ➡️ lnkd.in/gA_k2xEv

A new test that analyzes just a strand of hair is being hailed as a game-changer in the early detection of autism. firstalert4.com/2025/06/02/bre…